Sunil Healthcare (BOM:537253) Cyclically Adjusted Revenue per Share: ₹112.54 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:537253 Sunil Healthcare Ltd BOM:537253
58 GF Score
Price ₹70.78
GF Value ₹70.55
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare Cyclically Adjusted Revenue per Share?

Sunil Healthcare BOM:537253 -1.43% 58 Cyclically Adjusted Revenue per Share is ₹112.54 as of Mar. 2026. GuruFocus rates BOM:537253 with a GF Score™ of 58/100 and a GF Value™ of ₹70.55 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sunil Healthcare's adjusted revenue per share for the three months ended in Mar. 2026 was ₹19.253. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹112.54 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sunil Healthcare's average Cyclically Adjusted Revenue Growth Rate was 1.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sunil Healthcare was 2.10% per year. The lowest was 2.10% per year. And the median was 2.10% per year.

As of today (2026-08-13), Sunil Healthcare's current stock price is ₹70.78. Sunil Healthcare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹112.54. Sunil Healthcare's Cyclically Adjusted PS Ratio of today is 0.63.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sunil Healthcare was 1.67. The lowest was 0.46. And the median was 0.64.


Sunil Healthcare  (BOM:537253) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sunil Healthcare's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=70.78/112.54
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sunil Healthcare was 1.67. The lowest was 0.46. And the median was 0.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sunil Healthcare Cyclically Adjusted Revenue per Share Related Terms


Sunil Healthcare Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sunil Healthcare's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunil Healthcare Cyclically Adjusted Revenue per Share Chart

Sunil Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 105.68 110.40 111.25 112.54

Sunil Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.25 111.84 112.63 112.57 112.54

BOM:537253 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sunil Healthcare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunil Healthcare Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunil Healthcare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sunil Healthcare's Cyclically Adjusted PS Ratio falls into.


BOM:537253
58GF Score
Sunil Healthcare Ltd BOM:537253
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sunil Healthcare's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.253/164.2724*164.2724
=19.253

Current CPI (Mar. 2026) = 164.2724.

Sunil Healthcare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201509 16.551 101.753 26.720
201512 24.276 102.901 38.755
201603 22.153 102.518 35.497
201606 20.424 105.961 31.664
201609 23.614 105.961 36.609
201612 27.220 105.196 42.506
201703 27.098 105.196 42.316
201803 0.000 109.786 0.000
201806 19.061 111.317 28.129
201809 21.097 115.142 30.099
201812 20.541 115.142 29.306
201903 17.974 118.202 24.980
201906 17.743 120.880 24.112
201909 16.254 123.175 21.677
201912 17.694 126.235 23.026
202003 15.159 124.705 19.969
202006 20.582 127.000 26.622
202009 22.850 130.118 28.848
202012 23.206 130.889 29.125
202103 21.617 131.771 26.949
202106 25.488 134.084 31.226
202109 29.407 135.847 35.560
202112 30.722 138.161 36.528
202203 31.197 138.822 36.916
202206 32.569 142.347 37.585
202209 29.826 144.661 33.869
202212 25.374 145.763 28.596
202303 20.670 146.865 23.120
202306 22.098 150.280 24.156
202309 23.078 151.492 25.025
202312 22.668 152.924 24.350
202403 20.829 153.035 22.359
202406 20.833 155.789 21.967
202409 19.582 157.882 20.375
202412 20.067 158.323 20.821
202503 20.416 157.552 21.287
202506 22.198 159.755 22.826
202509 22.884 162.289 23.164
202512 21.269 163.281 21.398
202603 19.253 164.272 19.253

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹112.54 mean?
Sunil Healthcare (BOM:537253) has a Cyclically Adjusted Revenue per Share of ₹112.54 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sunil Healthcare and its competitors.
Is Sunil Healthcare's Cyclically Adjusted Revenue per Share too high?
Sunil Healthcare's current Cyclically Adjusted Revenue per Share is ₹112.54. Overall, Sunil Healthcare has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunil Healthcare's Cyclically Adjusted Revenue per Share compare to ZTS?
Sunil Healthcare's Cyclically Adjusted Revenue per Share of ₹112.54 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sunil Healthcare and its competitors. Sunil Healthcare's current Cyclically Adjusted Revenue per Share is ₹112.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunil Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sunil Healthcare (BOM:537253) is currently considered Fairly Valued. The stock's GF Value™ is ₹70.55, compared to a current price of ₹70.78 — trading 0.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹112.54. Sunil Healthcare's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sunil Healthcare (BOM:537253), the current Cyclically Adjusted Revenue per Share is ₹112.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunil Healthcare (BOM:537253) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be overvalued. The current stock price of ₹70.78 is trading 0.3% above its estimated GF Value™ of ₹70.55. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for BOM:537253:

  • Cyclically Adjusted Revenue per Share: ₹112.54
  • GF Value™: ₹70.55 vs. price of ₹70.78 (0.3% above fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the BOM:537253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunil Healthcare Business Description

Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
58GF Score

Get the complete analysis for BOM:537253

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹70.78
Price
₹70.55
GF Value